Trials / Completed
CompletedNCT01214850
Novartis Vaccine and Diagnostics Carriage Trial
A Phase 3 Observer Blind Randomized, Multi-center, Controlled Study to Evaluate the Effect of Novartis Vaccine's Meningococcal B Recombinant and MenACWY Conjugate Vaccines on Pharyngeal Carriage of N. Meningitidis in Young Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,968 (actual)
- Sponsor
- Novartis Vaccines · Industry
- Sex
- All
- Age
- 18 Years – 24 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this trial was to evaluate the effect of Novartis Vaccine's Meningococcal vaccines on carriage of Neisseria meningitidis in a young adult population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Meningococcal B Recombinant + Outer Membrane Vesicle vaccine (rMenB+OMV NZ) | |
| BIOLOGICAL | MenACWY-CRM conjugate vaccine | |
| BIOLOGICAL | Japanese Encephalitis vaccine |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-10-05
- Last updated
- 2016-04-21
- Results posted
- 2014-01-23
Locations
10 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01214850. Inclusion in this directory is not an endorsement.